Global Opioids Drug Competitive Landscape Professional Research Report 2025
Description
Global Opioids Drug Competitive Landscape Professional Research Report 2025
Research Summary
Opioids are a class of potent drugs that are commonly prescribed for pain relief due to their ability to interact with opioid receptors in the brain and body. Opioids can provide effective pain management for various conditions, including post-surgical recovery, severe injuries, and chronic pain. They work by altering the way pain signals are transmitted in the nervous system, leading to pain relief and a sense of euphoria. However, opioids also carry a high risk of addiction and dependency, and their misuse can lead to a range of negative health effects, including respiratory depression, overdose, and, in severe cases, death. Opioids can include prescription medications like morphine, oxycodone, and fentanyl, as well as illicit drugs such as heroin. Their use is closely monitored by healthcare providers to balance the need for pain relief with the potential risks of addiction and abuse.
According to DIResearch's in-depth investigation and research, the global Opioids Drug market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Opioids Drug include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, Johnson & Johnson, Endo, Pfizer, Mylan, INSYS, Hikma, Egalet etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Opioids Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Opioids Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Opioids Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Opioids Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Opioids Drug Include:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Endo
Pfizer
Mylan
INSYS
Hikma
Egalet
Opioids Drug Product Segment Include:
Oxycodone
Hydromorphone
Codeine
Fentanyl
Opioids Drug Product Application Include:
Pain Relief
Anesthesia
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Opioids Drug Industry PESTEL Analysis
Chapter 3: Global Opioids Drug Industry Porter’s Five Forces Analysis
Chapter 4: Global Opioids Drug Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Opioids Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Opioids Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Opioids Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Opioids Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Opioids Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Opioids Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Opioids Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Opioids Drug Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Opioids Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Opioids Drug Product by Type
- 1.2.1 Oxycodone
- 1.2.2 Hydromorphone
- 1.2.3 Codeine
- 1.2.4 Fentanyl
- 1.3 Opioids Drug Product by Application
- 1.3.1 Pain Relief
- 1.3.2 Anesthesia
- 1.3.3 Others
- 1.4 Global Opioids Drug Market Revenue and Sales Analysis
- 1.4.1 Global Opioids Drug Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Opioids Drug Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Opioids Drug Market Sales Price Trend Analysis (2020-2032)
- 1.5 Opioids Drug Industry Trends and Innovation
- 1.5.1 Opioids Drug Industry Trends and Innovation
- 1.5.2 Opioids Drug Market Drivers and Challenges
- 2 Opioids Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Opioids Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Opioids Drug Market Analysis by Regions
- 4.1 Opioids Drug Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Opioids Drug Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Opioids Drug Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Opioids Drug Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Opioids Drug Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Opioids Drug Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Opioids Drug Sales Forecast by Region (2026-2032)
- 4.4 Global Opioids Drug Sales Price Trend Analysis (2020-2032)
- 5 Global Opioids Drug Market Size by Type and Application
- 5.1 Global Opioids Drug Market Size by Type
- 5.1.1 Global Opioids Drug Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Opioids Drug Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Opioids Drug Market Size by Application
- 5.2.1 Global Opioids Drug Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Opioids Drug Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Opioids Drug Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Opioids Drug Market Size by Type
- 6.3.1 North America Opioids Drug Sales by Type (2020-2032)
- 6.3.2 North America Opioids Drug Revenue by Type (2020-2032)
- 6.4 North America Opioids Drug Market Size by Application
- 6.4.1 North America Opioids Drug Sales by Application (2020-2032)
- 6.4.2 North America Opioids Drug Revenue by Application (2020-2032)
- 6.5 North America Opioids Drug Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Opioids Drug Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Opioids Drug Market Size by Type
- 7.3.1 Europe Opioids Drug Sales by Type (2020-2032)
- 7.3.2 Europe Opioids Drug Revenue by Type (2020-2032)
- 7.4 Europe Opioids Drug Market Size by Application
- 7.4.1 Europe Opioids Drug Sales by Application (2020-2032)
- 7.4.2 Europe Opioids Drug Revenue by Application (2020-2032)
- 7.5 Europe Opioids Drug Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Opioids Drug Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Opioids Drug Market Size by Type
- 8.3.1 China Opioids Drug Sales by Type (2020-2032)
- 8.3.2 China Opioids Drug Revenue by Type (2020-2032)
- 8.4 China Opioids Drug Market Size by Application
- 8.4.1 China Opioids Drug Sales by Application (2020-2032)
- 8.4.2 China Opioids Drug Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Opioids Drug Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Opioids Drug Market Size by Type
- 9.3.1 APAC (excl. China) Opioids Drug Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Opioids Drug Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Opioids Drug Market Size by Application
- 9.4.1 APAC (excl. China) Opioids Drug Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Opioids Drug Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Opioids Drug Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Opioids Drug Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Opioids Drug Market Size by Type
- 10.3.1 Latin America Opioids Drug Sales by Type (2020-2032)
- 10.3.2 Latin America Opioids Drug Revenue by Type (2020-2032)
- 10.4 Latin America Opioids Drug Market Size by Application
- 10.4.1 Latin America Opioids Drug Sales by Application (2020-2032)
- 10.4.2 Latin America Opioids Drug Revenue by Application (2020-2032)
- 10.5 Latin America Opioids Drug Market Size by Country
- 10.6 Latin America Opioids Drug Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Opioids Drug Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Opioids Drug Market Size by Type
- 11.3.1 Middle East & Africa Opioids Drug Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Opioids Drug Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Opioids Drug Market Size by Application
- 11.4.1 Middle East & Africa Opioids Drug Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Opioids Drug Revenue by Application (2020-2032)
- 11.5 Middle East Opioids Drug Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Opioids Drug Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Opioids Drug Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Opioids Drug Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Opioids Drug Average Sales Price by Manufacturers (2021-2025)
- 12.2 Opioids Drug Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Opioids Drug Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Teva
- 13.1.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Teva Opioids Drug Product Portfolio
- 13.1.3 Teva Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Purdue Pharma
- 13.2.1 Purdue Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Purdue Pharma Opioids Drug Product Portfolio
- 13.2.3 Purdue Pharma Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Mallinckrodt
- 13.3.1 Mallinckrodt Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Mallinckrodt Opioids Drug Product Portfolio
- 13.3.3 Mallinckrodt Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Amneal Pharma
- 13.4.1 Amneal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Amneal Pharma Opioids Drug Product Portfolio
- 13.4.3 Amneal Pharma Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Collegium
- 13.5.1 Collegium Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Collegium Opioids Drug Product Portfolio
- 13.5.3 Collegium Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Johnson & Johnson
- 13.6.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Johnson & Johnson Opioids Drug Product Portfolio
- 13.6.3 Johnson & Johnson Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Endo
- 13.7.1 Endo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Endo Opioids Drug Product Portfolio
- 13.7.3 Endo Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Pfizer
- 13.8.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Pfizer Opioids Drug Product Portfolio
- 13.8.3 Pfizer Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Mylan
- 13.9.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Mylan Opioids Drug Product Portfolio
- 13.9.3 Mylan Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 INSYS
- 13.10.1 INSYS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 INSYS Opioids Drug Product Portfolio
- 13.10.3 INSYS Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 Hikma
- 13.11.1 Hikma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Hikma Opioids Drug Product Portfolio
- 13.11.3 Hikma Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.12 Egalet
- 13.12.1 Egalet Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Egalet Opioids Drug Product Portfolio
- 13.12.3 Egalet Opioids Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Opioids Drug Industry Chain Analysis
- 14.2 Opioids Drug Industry Raw Material and Suppliers Analysis
- 14.2.1 Opioids Drug Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Opioids Drug Typical Downstream Customers
- 14.4 Opioids Drug Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
